MDLN vs. THC: Medline vs. Tenet Healthcare Stock Comparison

Company Profile

Medline (MDLN) and Tenet Healthcare (THC) both fall under the Health Care Equipment & Services industry group, but MDLN is classified in Health Care Equipment & Supplies while THC is classified in Health Care Providers & Services.

Tenet Healthcare (THC) has been public since March 17, 1980, giving it decades of market history across multiple cycles, while Medline (MDLN) listed only on December 17, 2025 and lacks comparable through-cycle data.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Medline (MDLN) reports a negative beta of -0.93, suggesting inverse market sensitivity over the measurement window. That is uncommon for ordinary equities and can reflect commodity-linked or hedge-like exposure, but it can also come from statistical noise. Tenet Healthcare (THC) has a non-negative beta of 1.17.

Risk-Adjusted Performance

Risk-Return Positioning

Both MDLN and THC need 1-year volatility and 1-year return to plot risk-return positioning.

Risk-Adjusted Metrics

Profitability

Tenet Healthcare (THC) at 41.70% sits in the top ROE quartile, while Medline (MDLN) at 4.85% is closer to the peer norm — stronger capital efficiency for THC.

Tenet Healthcare (THC) at 13.09% retains a top-quartile share of revenue as profit, ahead of Medline (MDLN) at 1.85%, which keeps about the industry-typical share.

Tenet Healthcare (THC) at 19.04% operates in the top operating margin quartile, ahead of Medline (MDLN) at 5.22%, which runs around its industry’s norm.

Profitability Metrics

Growth

Only one side can be read here: Tenet Healthcare (THC) reports revenue growth of 3.07%, ranked against its industry; Medline (MDLN) has no revenue growth figure this period.

Medline (MDLN) at 117.38% delivers above-range EPS growth, while Tenet Healthcare (THC) at -52.63% falls into the bottom quartile — a wide split in earnings momentum.

Growth Metrics

Financial Strength

Tenet Healthcare (THC) at 1.59 keeps current ratio within its industry’s typical mid-range, while Medline (MDLN) at 4.04 sits above its industry’s typical mid-range — comfortable liquidity, though possibly with more idle current assets relative to peers.

Medline (MDLN) at 0.65 carries an industry-typical debt-to-equity mix, while Tenet Healthcare (THC) at 1.38 uses more debt funding than most peers.

Financial Strength Metrics

Dividends

Neither Medline (MDLN) nor Tenet Healthcare (THC) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Neither Medline (MDLN) nor Tenet Healthcare (THC) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Dividend Metrics

Valuation

Tenet Healthcare (THC) at 8.26 sits in the cheaper P/E ratio quartile, while Medline (MDLN) at 90.09 trades above its peer range — a wide earnings-valuation gap relative to industry peers.

Tenet Healthcare (THC) at 1.02 sits in the cheaper P/S ratio quartile while Medline (MDLN) at 1.70 prices around its industry’s middle — THC costs less per dollar of sales, though read it alongside growth and margins.

On P/B ratio, both Medline (MDLN) at 2.95 and Tenet Healthcare (THC) at 4.14 are valued close to their industries’ norm against book — neither stands out from peers.

Valuation Metrics